Innovation

Advancing dependable science, one program at a time.

Our R&D focuses on complex generics, improved delivery, and diagnostic precision — where better engineering translates directly into better access and better outcomes.

Pipeline

Programs in development

Development Current stage

ProgramAreaDiscovery → Filed

MX-114 (inhaled) Respiratory

MX-207 combination Anti-retroviral

MX-330 depot CNS

MX-451 assay Diagnostics

MX-508 biosimilar Specialty

DiscoveryPreclinicalPhase I–IIIFiled

Technologies

Where our advantage is engineered.

Inhalation delivery

Device-and-formulation engineering for consistent dosing in respiratory care.

Complex generics

Difficult-to-replicate formulations and fixed-dose combinations.

Assay precision

Reagent and control design that reduces pre-analytical variability.

Partner with us on complex development.

We collaborate with research groups and manufacturers on formulation, delivery, and diagnostic programs.

Start a conversation →